-
Vasoreactivity Testing in Pulmonary Arterial Hypertension
Should we still do vasoreactivity testing in a patient diagnosed with pulmonary arterial hypertension (PAH)?
Medscape Cardiology, April 2007
-
Evaluating the Lung in Connective Tissue Disease
How do we evaluate the lung in connective tissue disease?
Medscape Cardiology, April 2007
-
RSVP Measurements and Pulmonary Arterial Hypertension
A reader asks: How do you define PAH with the RVSP measurement?
Medscape Cardiology, March 2007
-
Is Pulmonary Arterial Hypertension Ever Reversible?
A reader asks: Is pulmonary arterial hypertension ever reversible? Is it curable?
Medscape Cardiology, March 2007
-
Complications Associated With Pulmonary Arterial Hypertension
How does right ventricular dysfunction leading to right heart failure affect patients with PAH?
Medscape Cardiology, February 2007
-
Defining Pulmonary Hypertension
What is the difference between pulmonary hypertension and pulmonary arterial hypertension?
Medscape Cardiology, February 2007
-
Pulmonary Hypertension and Inhaled Nitric Oxide Therapy
When should inhaled nitric oxide therapy be used in PAH?
Medscape Cardiology, January 2007
-
Calcium Channel Blockers and Pulmonary Hypertension
Is vasoreactivity testing necessary in PAH patients receiving CCBs?
Medscape Cardiology, January 2007
-
The Initial Workup of Patients With Heart Disease and PAH
There is little data on the approach to the initial workup of patients with heart disease and PAH. What should you look for?
Medscape Cardiology, December 2006
-
Pulmonary Vasodilators?
In patients with PAH and only mildly elevated pulmonary capillary wedge pressure (16-22 mm Hg), would you try treatment with pulmonary vasodilators?
Medscape Cardiology, December 2006
-
Pulmonary Hypertension and COPD
Why do some COPD patients develop pulmonary hypertension after surgery?
Medscape Cardiology, November 2006
-
Refractory Pulmonary Venoocclusive Disease?
Although PVOD is characterized under WHO Group I pulmonary arterial hypertension (PAH), in many respects it is a "different animal."
Medscape Cardiology, November 2006
-
How Long Should Patients Be Monitored Following Outpatient Cardioversion?
Should it be a standard of care to use telemetry or cardiac monitoring after outpatient cardioversion for atrial fibrillation? If so, how long should monitoring be continued?
Medscape Nurses, September 2006
-
Do ED Physicians Need to Know About Pulmonary Arterial Hypertension?
Why should emergency physicians keep their knowledge base of pulmonary hypertension updated?
Medscape Cardiology, September 2006
-
The Classification of Pulmonary Arterial Hypertension
Why does the literature sometimes refer to WHO functional class and sometimes to NYHA functional class? What is the difference?
Medscape Cardiology, September 2006
-
Pulmonary Hypertension and Idiopathic Pulmonary Fibrosis
A reader asks, "Is pulmonary arterial hypertension common in cases of IPF?"
Medscape Cardiology, August 2006
-
Updating the Definition of PAH
The classification scheme describing pulmonary arterial hypertension has recently been revised. Updates to treatment algorithms are needed.
Medscape Pulmonary Medicine, February 2006
-
What Are the Risks of Central Adiposity in Women?
We know that "pear-shaped" women are at less risk for heart disease than "apple-shaped" women. When weight shifts to the abdomen in menopause, does this put them at the same increased risk?
Medscape Nurses, February 2006
-
Vancomycin Duration of Treatment
How long should a patient receive vancomycin therapy? A number of patient factors must be considered.
Medscape Pharmacists, October 2005
-
Carotid Endarterectomy for Asymptomatic Severe Stenosis of Internal Carotid Arteries
What is the current recommendation regarding carotid endarterectomy for asymptomatic severe stenosis of internal carotid arteries?
Medscape Neurology & Neurosurgery, October 2004
